• Medientyp: E-Artikel
  • Titel: Anxiety and depression in patients with Barrett’s esophagus: estimates of disorder rates and associations with symptom load and treatment-seeking
  • Beteiligte: Treml, Julia; Kreuser, Nicole; Gockel, Ines; Kersting, Anette
  • Erschienen: Ovid Technologies (Wolters Kluwer Health), 2021
  • Erschienen in: European Journal of Gastroenterology & Hepatology
  • Sprache: Englisch
  • DOI: 10.1097/meg.0000000000001960
  • ISSN: 0954-691X
  • Schlagwörter: Gastroenterology ; Hepatology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:sec> <jats:title>Background</jats:title> <jats:p>Patients with Barrett’s esophagus (BE) may experience psychological burden from living with a chronic medical condition, which has been identified as the most important risk factor for esophageal adenocarcinoma. The aim of this study was to estimate rates of depression and anxiety in a large sample of patients with BE.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>A total of 794 patients with endoscopically and histologically confirmed diagnosis of BE completed validated screening instruments for depression (Patient Health Questionnaire-9) and anxiety (Generalized Anxiety Disorder-7). Screening rates in the study sample were compared to general population estimates. Multivariable regression analyses were used to model associations between outcome variables and respondents’ sociodemographic characteristics, BE-related symptom load and incidence of inpatient treatment due to BE in the last 12 months.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Rates of positive screens were 14.2% for depression and 9.9% for anxiety. For several age by sex subgroups, rates of depression and anxiety were about three to five times higher in the study sample than in the general population. BE-related reflux and pain symptoms showed strong associations with higher levels of depressive and anxiety symptoms, while the effect of treatment was small.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>Study results indicate that a relevant proportion of patients with BE is at an increased risk for depression and anxiety, compared to general population controls. Lacking information on patients’ disease characteristics limited generalizability of results.</jats:p> </jats:sec>